| Literature DB >> 31886456 |
Djamilia Dierov1, Nicholas Webb1, Samira Fatmi1, Chamberlain Nwanne2, Cristi Ciolino1, Kara Mosesso1, Jimmy Nieves1, Miguel-Angel Perales1,3, Susan E Prockop4, Doris M Ponce1,3.
Abstract
GVHD is a frequent complication following allo-HCT. The NIH consensus group established new guidelines for the evaluation of chronic GVHD. However, GVHD assessment remains challenging due its complexity and requirement for laborious evaluation. We, therefore, established a standardized approach for the assessment of chronic GVHD in accordance with the NCC guidelines. At a single institution, all allograft recipients were evaluated for GVHD within the first-year post allo-HCT following a 3-step workflow (real-time assessment, consensus review, and documentation). A GVHD adjudication committee was created and a dynamic electronic GVHD data capture form was developed guiding the clinician through a comprehensive review of systems following the NCC guidelines. We found that the assessment and reporting of GVHD reached 100% compliance. The establishment of an institutional GVHD adjudication committee enabled standardized assessment of GVHD. Our workflow can be adopted by other centers to create a similar framework for dedicated GVHD evaluation.Entities:
Keywords: GVHD; data management; quality improvement
Year: 2019 PMID: 31886456 PMCID: PMC6934358 DOI: 10.1002/acg2.62
Source DB: PubMed Journal: Adv Cell Gene Ther ISSN: 2573-8461